Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03198871 · ClinicalTrials.gov registry record · Phase 4
IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population
A Phase 4 study, sponsored by Kathirvel Subramaniam.
- Completed
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT03198871 is a Phase 4 study that has completed, run by Kathirvel Subramaniam. The registered enrollment target is 180 participants.
The verdict
NCT03198871, a Phase 4 study, has completed, sponsored by Kathirvel Subramaniam.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
Number of patients with unsatisfactory pain relief defined as average visual analog scale (VAS) more than 5 with or without requirement of IVPCA for pain relief during the first 48 hours postoperative period will be compared between the two groups and form the primary outcome for the study. Postoperative pain intensity will be measured by Visual Analog Scale (VAS) with 0- being no pain and 10-being maximum pain and the analgesic efficacy in both groups will also be evaluated by the amount of total narcotic consumption (measured with IV morphine equivalent doses of analgesics used to provide pain relief).
Interventions
- DRUG Acetaminophen Injectable Product
- DRUG Sodium Chloride 0.9%, Intravenous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-05-24 |
| Est. Completion | 2020-11-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03198871
The ClinicalTrials.gov registry entry for NCT03198871 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kathirvel Subramaniam, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen Injectable Product is the first listed.
NCT03198871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03198871 about?
NCT03198871 is a clinical study titled "IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population". Number of patients with unsatisfactory pain relief defined as average visual analog scale (VAS) more than 5 with or without requirement of IVPCA for pain relief during the first 48 hours postoperative period will be compared between the two groups and form the primary outcome for the study. Postoper...
What is the current status of trial NCT03198871?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2018-05-24. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT03198871?
The interventions under investigation include: Acetaminophen Injectable Product (DRUG), Sodium Chloride 0.9%, Intravenous (DRUG).
Who is sponsoring clinical trial NCT03198871?
This trial is sponsored by Kathirvel Subramaniam, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.